Sonnet BioTherapuetics(SONN)
Search documents
Sonnet BioTherapuetics(SONN) - 2023 Q2 - Quarterly Report
2023-05-10 11:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-35570 SONNET BIOTHERAPEUTICS HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-2932652 (State or O ...
Sonnet BioTherapuetics(SONN) - 2023 Q1 - Quarterly Report
2023-02-13 13:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-35570 SONNET BIOTHERAPEUTICS HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-2932652 (State o ...
Sonnet BioTherapuetics(SONN) - 2019 Q2 - Earnings Call Transcript
2019-08-15 02:57
Chanticleer Holdings, Inc. (BURG) Q2 2019 Results Earnings Conference Call August 15, 2019 4:30 PM ET Company Participants Jason Assad - Head of IR Michael Pruitt - Chairman and CEO Patrick Harkleroad - CFO Fred Glick - President Conference Call Participants David Burdick - Oak Ridge John O'Shea - Global Alliance Operator Welcome to the Chanticleer HoldingsÂ' Q2 2019 Conference Call. As a reminder, all participants are in a listen-only mode and the conference is being recorded. At this time, I would like to ...
Sonnet BioTherapuetics(SONN) - 2019 Q1 - Earnings Call Transcript
2019-05-15 23:00
Chanticleer Holdings, Inc. (BURG) Q1 2019 Earnings Conference Call May 15, 2019 4:30 PM ET Company Participants Jason Assad - Head of Investor Relations Michael Pruitt - Chairman and Chief Executive Officer Patrick Harkleroad - Chief Financial Officer Fred Glick - President Conference Call Participants Operator Welcome to the Chanticleer HoldingsÂ' First Quarter 2019 Conference Call. As a reminder, all participants are in a listen-only mode and the conference is being recorded. At this time, I would like to ...
Sonnet BioTherapuetics(SONN) - 2018 Q4 - Earnings Call Transcript
2019-04-02 03:00
Chanticleer Holdings, Inc. (BURG) Q4 2018 Earnings Conference Call April 1, 2019 4:30 PM ET Company Participants Jason Assad - Head of Investor Relations Michael Pruitt - Chairman and Chief Executive Officer Patrick Harkleroad - Chief Financial Officer Fred Glick - President Conference Call Participants Mark Smith - Oak Ridge Financials Mike Grondahl - Northland Securities, Inc. Ben Rabizadeh - Ascending Capital Operator Greetings, and welcome to the Chanticleer Holdings, Inc. Fourth Quarter and Year-End 20 ...